Docket #: S11-119
Self-anchoring Nerve Block Catheters
The self-anchoring indwelling nerve block catheter permits, via percutaneous administration, continuous and/or intermittent infusion of local anesthetics and adjuvant analgesics for peripheral nerve and plexus anesthesia for surgical anesthesia and pain management. The device consists of the peripheral nerve block needle, the nerve block catheter, and related dressing accessory to secure an indwelling catheter in position for up to 72 hours. The allows for targeted anesthetic delivery following catheter placement, and incorporates a deployable anchoring system that secures the catheter while in situ, preventing its accidental dislodgment or movement. The anchoring system can be safely disengaged for easy removal of the catheter at the end of therapy.
Stage of Research
FDA 510(k) clearance
Applications
- Pain management
- Local anesthetic delivery during surgical procedures
- Local anesthetic delivery during the postopertative period
Advantages
- Peripheral nerve and nerve plexus anesthetic delivery in a single device that anchors to tissue for long term security
- To remain indwelling for up to 72 hours
- FDA 510(k) clearance
Patents
- Published Application: 20110218529
- Published Application: 20140364798
- Published Application: WO2014113721
- Published Application: 20150306350
- Issued: 8,825,129 (USA)
- Issued: 9,511,206 (USA)
Similar Technologies
-
Ultrasonic neuromodulation with Pattern Interference Radiation Force (PIRF) S16-382Ultrasonic neuromodulation with Pattern Interference Radiation Force (PIRF)
-
Improved Pain Suppression with Targeted Ultrasound S23-109Improved Pain Suppression with Targeted Ultrasound
-
A Device to Control Peripheral Nervous Tissue Containing Light-Gated Channels S08-033A Device to Control Peripheral Nervous Tissue Containing Light-Gated Channels